COVID-19 Vaccine Race: With Moderna EUA, US FDA Finally Gets Some Bragging Rights

 
• By Derrick Gingery and Nielsen Hobbs

US FDA’s global first for Moderna’s vaccine gets a small mention as agency looks to pharmacovigilance, follow-up studies for both coronavirus inoculations that have now been authorized. Moderna's 18 December EUA comes after an even faster review than for Pfizer/BioNTech's vaccine.

number 2
We're Number 2! The FDA's EUA for Moderna's coronavirus vaccine clears the way for more immunizations to occur, likely in the coming days. • Source: Shutterstock

More from US FDA

More from Agency Leadership